Eurobio Scientific Société anonyme

EPA:ALERS.PA

24.95 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q22008 Q12007 Q42007 Q32007 Q22007 Q1
Revenue 70.84559.15868.85283.75588.98195.731126.60762.24929.58429.62526.02725.04423.24819.53212.78515.0413.79715.98314.89216.15215.31615.901.34701.34701.24801.24802.04302.04301.2231.2231.2231.0551.0551.0551.0551.3461.3461.3461.346
Cost of Revenue 41.19535.48541.71945.84543.51243.75748.67834.56823.63418.82417.19416.28815.64714.17510.19312.82112.54412.54511.26811.79311.33712.22600.11200.1120000000002.2462.2462.2462.472.472.472.472.1522.1522.1522.152
Gross Profit 29.6523.67327.13337.9145.46951.97477.92927.6815.9510.8018.8338.7567.6015.3572.5922.2191.2533.4383.6244.3593.9793.67401.23501.23501.24801.24802.04302.0430-1.023-1.023-1.023-1.415-1.415-1.415-1.415-0.806-0.806-0.806-0.806
Gross Profit Ratio 0.4190.40.3940.4530.5110.5430.6160.4450.2010.3650.3390.350.3270.2740.2030.1480.0910.2150.2430.270.260.23100.91700.917010101010-0.836-0.836-0.836-1.341-1.341-1.341-1.341-0.599-0.599-0.599-0.599
Reseach & Development Expenses 2.3822.882.0721.1011.8171.011.1930.7040.8030.5681.0530.3680.8461.2611.2911.872.3781.5872.8392.8033.7383.60801.74601.74601.92901.92902.1202.12000000000000
General & Administrative Expenses 8.8785.3955.1156.2822.6754.7442.8213.3921.2192.7812.5342.7742.6682.7871.9412.2272.212.3452.8582.0773.3023.19301.10701.10701.34301.34301.72801.72801.3921.3921.3921.4341.4341.4341.4341.1431.1431.1431.143
Selling & Marketing Expenses 11.4497.810.7148.8898.4848.5968.7097.5815.2365.7045.8774.7756.8464.6254.0174.3164.0654.5184.9114.1884.2763.65600.22500.22500.37700.37700.33400.33400.310.310.310.2860.2860.2860.2860.2620.2620.2620.262
SG&A 20.32713.19515.82915.17112.13912.3612.519.9935.4768.4858.4117.5499.5147.4125.9586.5436.2756.8637.7696.2657.5786.84901.33201.33201.7201.7202.06202.06201.7021.7021.7021.721.721.721.721.4051.4051.4051.405
Other Expenses -0.869-3.529-0.1490.3171.87000000000000000000-5.9780-5.9780-0.1230-0.1230-7.9680-7.9680-3.094-3.094-3.094-3.154-3.154-3.154-3.154-2.547-2.547-2.547-2.547
Operating Expenses 23.57819.60418.0515.95512.08613.3713.70310.6976.2799.6869.9659.42911.5310.0416.5536.2884.9935.8157.4616.7357.697.0450-2.9010-2.90103.52603.5260-3.7860-3.7860-1.392-1.392-1.392-1.434-1.434-1.434-1.434-1.143-1.143-1.143-1.143
Operating Income 6.0724.0699.08321.95533.38338.60464.22616.984-0.3290.897-0.996-0.163-3.264-2.521-3.124-4.266-4.821-3.521-3.654-2.033-3.753-3.2710-1.6660-1.6660-2.0240-2.0240-1.7440-1.7440-2.415-2.415-2.415-2.849-2.849-2.849-2.849-1.949-1.949-1.949-1.949
Operating Income Ratio 0.0860.0690.1320.2620.3750.4030.5070.273-0.0110.03-0.038-0.007-0.14-0.129-0.244-0.284-0.349-0.22-0.245-0.126-0.245-0.2060-1.2370-1.2370-1.6210-1.6210-0.8540-0.8540-1.975-1.975-1.975-2.701-2.701-2.701-2.701-1.447-1.447-1.447-1.447
Total Other Income Expenses Net -1.998-1.166-1.7130.358-0.533-0.142-0.113-0.208-0.227-0.177-0.752-0.908-1.08-2.413-0.9520.090.8551.012-0.381-0.3950.004-0.1110-0.0120-0.0120-0.0270-0.0270-0.5260-0.52600.0860.0860.0860.0950.0950.0950.095-0.055-0.055-0.055-0.055
Income Before Tax 4.0742.9037.3722.31332.8538.46264.11316.776-0.5560.72-1.748-1.071-4.344-4.934-4.076-4.176-3.966-2.509-4.035-2.428-3.749-3.3820-1.6780-1.6780-2.0510-2.0510-2.2690-2.2690-2.329-2.329-2.329-2.754-2.754-2.754-2.754-2.004-2.004-2.004-2.004
Income Before Tax Ratio 0.0580.0490.1070.2660.3690.4020.5060.269-0.0190.024-0.067-0.043-0.187-0.253-0.319-0.278-0.287-0.157-0.271-0.15-0.245-0.2130-1.2460-1.2460-1.6430-1.6430-1.1110-1.1110-1.905-1.905-1.905-2.611-2.611-2.611-2.611-1.488-1.488-1.488-1.488
Income Tax Expense 1.430.7121.6553.0915.3675.40116.317-8.909-3.3580.3690.1240.1750.6580.0330.2520.2680.3590.2410.4920.4880.4810.6560-0.2360-0.2360-0.2760-0.2760-0.3320-0.3320-0.404-0.404-0.404-0.522-0.522-0.522-0.522-0.169-0.169-0.169-0.169
Net Income 2.6442.1915.71519.22227.48333.06147.79625.6852.8020.351-1.872-0.896-5.001-4.968-3.824-3.909-3.608-2.271-3.547-1.94-3.268-2.7260-1.4430-1.4430-1.7750-1.7750-1.9370-1.9370-1.925-1.925-1.925-2.232-2.232-2.232-2.232-1.835-1.835-1.835-1.835
Net Income Ratio 0.0370.0370.0830.230.3090.3450.3780.4130.0950.012-0.072-0.036-0.215-0.254-0.299-0.26-0.262-0.142-0.238-0.12-0.213-0.1710-1.0710-1.0710-1.4220-1.4220-0.9480-0.9480-1.574-1.574-1.574-2.116-2.116-2.116-2.116-1.363-1.363-1.363-1.363
EPS 0.290.210.561.862.532.934.242.280.260.03-0.19-0.092-0.49-0.67-0.96-1.02-1-0.65-1.11-0.65-1.13-10-0.80-0.80-1.050-1.050-1.170-1.170-1.37-1.37-1.37-1.67-1.67-1.67-1.67-1.44-1.44-1.44-1.44
EPS Diluted 0.290.210.561.862.532.894.172.260.250.032-0.19-0.092-0.49-0.67-0.96-1-1-0.6-1.11-0.65-1.13-0.970-0.80-0.80-1.050-1.050-1.170-1.170-1.37-1.37-1.37-1.67-1.67-1.67-1.67-1.44-1.44-1.44-1.44
EBITDA 13.6579.62914.61425.94535.8943.96269.35921.7045.7334.042-0.662.9080.584-0.486-1.912-3.042-3.554-2.515-2.417-0.944-2.566-2.0930-1.6490-1.6490-2.0510-2.0510-2.2690-2.2690-2.329-2.329-2.329-2.754-2.754-2.754-2.754-2.004-2.004-2.004-2.004
EBITDA Ratio 0.1930.1630.2120.310.4030.4590.5480.3490.1940.136-0.0250.1160.025-0.025-0.15-0.202-0.258-0.157-0.162-0.058-0.168-0.1320-1.2240-1.2240-1.6430-1.6430-1.1110-1.1110-1.905-1.905-1.905-2.611-2.611-2.611-2.611-1.488-1.488-1.488-1.488